S.No	TCGA	Study Name	N (tumor)	N (normal)
1	ACC	Adrenocortical carcinoma	77	128
2	BLCA	Bladder Urothelial Carcinoma	404	28
3	BRCA	Breast invasive carcinoma	1085	291
4	CESC	Cervical squamous cell carcinoma & endocervical adenocarcinoma	305	13
5	CHOL	Cholangiocarcinoma	36	9
6	COAD	Colon adenocarcinoma	275	349
7	DLBC	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	47	337
8	ESCA	Esophageal carcinoma	182	286
9	GBM	Glioblastoma multiforme	163	207
10	HNSC	Head and Neck squamous cell carcinoma	519	44
11	KICH	Kidney Chromophobe	66	53
12	KIRC	Kidney renal clear cell carcinoma	523	100
13	KIRP	Kidney renal papillary cell carcinoma	286	60
14	LAML	Acute Myeloid Leukemia	173	70
15	LGG	Brain Lower Grade Glioma	518	207
16	LIHC	Liver hepatocellular carcinoma	369	160
17	LUAD	Lung adenocarcinoma	483	347
18	LUSC	Lung squamous cell carcinoma	486	338
19	MESO	Mesothelioma	87	426
20	OV	Ovarian serous cystadenocarcinoma	88	179
21	PAAD	Pancreatic adenocarcinoma	179	171
22	PCPG	Pheochromocytoma and Paraganglioma	182	3
23	PRAD	Prostate adenocarcinoma	492	152
24	READ	Rectum adenocarcinoma	92	318
25	SARC	Sarcoma	262	2
26	SKCM	Skin Cutaneous Melanoma	461	558
27	STAD	Stomach adenocarcinoma	408	211
28	TGCT	Testicular Germ Cell Tumors	137	165
29	THCA	Thyroid carcinoma	512	337
30	THYM	Thymoma	118	339
31	UCEC	Uterine Corpus Endometrial Carcinoma	174	91
32	UCS	Uterine Carcinosarcoma	57	78
33	UVM	Uveal Melanoma	79	0